Canadian Association of Neuroscience Nurses

Canadian Association of Neuroscience Nurses Founded in 1969

Submit an abstract for presentation to our 57th Annual Meeting and Scientific Sessions! All topics and health care pro...
11/27/2025

Submit an abstract for presentation to our 57th Annual Meeting and Scientific Sessions! All topics and health care providers welcomed! đź“Š Submission is free, deadline is January 18th, 2026.
Registration will open early February 2026, www.cannmore2026.dryfta.com

🧠Visit www.cann.ca to join today, and enjoy the benefits of CANN membership!🧠

11/25/2025

KHSC and Queen’s neurosurgeon-scientists develop a low-cost tool to collect MRI-linked tumor samples for aggressive form of brain cancer.

11/25/2025

Today, ICN President Jose Luis Cobos, VPs Sineva Maria Ribeiro & Megumi Yamaura-Teshima, and CEO Howard Catton met with International Labour Organization Policy Director Frank Hagemann and Health Services Lead Maren Hopfe.
Together, we reaffirmed our continued commitment and collaboration on key priorities which included:
•Ensuring decent work for all personnel and tackling violence and harassment in the workplace
•Promoting wider ratification of the Nursing Personnel Convention (C149) to protect and support the workforce
•Sharing ICN’s new definition of a and nursing, to inform ILO’s future framework
This meeting reinforced our strong partnership with aligned goals, and together we will continue to advocate for the conditions deserve and the recognition the profession needs.

11/25/2025

A message from the Chief Nursing Officer of Canada, Dr. Leigh Chapman.

We are honoured to share a special message from Dr. Leigh Chapman, Chief Nursing Officer of Canada, as part of National Nursing Students’ Week. Her words remind us of the vital role nursing students play in shaping the future of Canada’s health system, and the strength, compassion, and leadership you bring to every space you enter.

Thank you, Dr. Chapman, for your continued support of nursing students across the country.

The ACT trial PI team also are 🇨🇦, based in Calgary
11/25/2025

The ACT trial PI team also are 🇨🇦, based in Calgary

11/25/2025

Dr. Michael Hill co-led a clinical trial of endovascular treatment (EVT) for ischemic stroke, called ESCAPE. EVT reduced the death rate by 50 percent, and in some cases, patients were discharged from hospital within two days post-treatment.
Read more: https://bit.ly/3LUNEdd.

🙏 🥲Thank you to our amazing Canadian researchers Canadian Neurological Sciences Federation - CNSF
11/25/2025

🙏 🥲Thank you to our amazing Canadian researchers Canadian Neurological Sciences Federation - CNSF

11/24/2025

Analysis of Factors and Clinical Outcomes of Planned Tracheal Extubation Failure in Neurosurgical Intensive Care Unit PatientsPlanned tracheal extubation fai...

11/24/2025

In cherished memory of Dr. Balfour Mount (1939–2025), Palliative Care McGill and the Canadian Society of Palliative Medicine invite you to join a virtual Memorial on Thursday December 4, 11:00 AM – 12:30 PM EST.

Moderated by Dr Justin Sanders, Director of Palliative Care McGill, McGill University, and Dr John Scott, President, Canadian Society of Palliative Medicine, with tributes from many international colleagues and friends including renowned figures in palliative care: Ira Byock, Kathy Foley, Richard Cruess, Sue Britton, Johanne de Montigny, and many others.

To register for the online memorial, please visit https://loom.ly/oRKKvVY.

11/24/2025

« Mes recherches, qui visent à mettre au jour les mécanismes en jeu et à déterminer si les médicaments existants peuvent rétablir le fonctionnement normal, pourraient déboucher sur de nouveaux traitements ciblant directement les causes profondes de la SLA liée au gène C9orf72, dans le but de ralentir la progression de la maladie et d'améliorer la qualité de vie des patients. »

Bryan Kartono, doctorant à University of Toronto, poursuit ses recherches sur l'influence du gène C9orf72 sur la fonction synaptique, c'est-à-dire les connexions entre les neurones, grâce au soutien des Prix des stagiaires de la Société canadienne de la SLA et de Brain Canada Il explore les voies moléculaires par lesquelles un médicament appelé lorlatinib pourrait aider à traiter le dysfonctionnement synaptique dans la SLA.

Pour en savoir plus sur ses recherches, rendez-vous sur https://bit.ly/3K5nmVa. (disponible en anglais seulement)

11/24/2025

Promising new treatments for multiple sclerosis (MS) are on the horizon - and The Neuro’s Clinical Research Unit is helping bring them closer.

“The majority of patients diagnosed today will live without new attacks or new lesions on their brain or spinal cord. That is very different from a patient’s experience just a decade ago.” – Dr. Adil Harroud, who is leading clinical trials exploring therapies that could ease difficult MS symptoms and improve long-term disease management.

Harroud is currently leading two innovative clinical trials: one testing an eye-tracking app to detect early changes in brain function, and another investigating a novel therapy to ease spasticity, a common and challenging MS symptom.

🧠 Learn more about what’s next in MS research: https://cru.mcgill.ca/advances-ms/
📧 For more information about current trials: https://cru.mcgill.ca/trials/

-------

De nouveaux traitements prometteurs pour la sclérose en plaques (SP) se profilent à l’horizon — et l’Unité de recherche clinique du Neuro () contribue à les rapprocher.

« La majorité des patients diagnostiqués aujourd’hui vivront sans nouvelles poussées ni nouvelles lésions au cerveau ou à la moelle épinière. C’est très différent de l’expérience des patients d’il y a seulement dix ans. » – Dr Adil Harroud, qui dirige des essais cliniques sur des thérapies visant à soulager les symptômes difficiles de la SP et à améliorer la gestion à long terme de la maladie.

Le Dr Harroud mène actuellement deux essais cliniques novateurs : l’un teste une application de suivi oculaire pour détecter précocement des changements dans le fonctionnement du cerveau, et l’autre évalue une nouvelle thérapie visant à réduire la spasticité, un symptôme fréquent et difficile de la SP.

🧠 Pour en savoir plus sur les prochaines avancées de la recherche sur la SP : https://cru.mcgill.ca/fr/avancees-sp/

McGill University McGill Faculty of Medicine and Health Sciences Centre universitaire de santé McGill - McGill University Health Centre MS Canada

11/24/2025

Check out our impact from 2021-25 in numbers! Our donations tripled, produced engaging video series on inclusive education, held many policy forums, and engaged with hundreds of diverse partners to advance our work. Stay tuned in the coming weeks as we share more of our work in specific priority areas.

Read the full impact report here below 👇
EN: https://bit.ly/3XBZnjk
FR: https://bit.ly/3JUzCrs

Address

PO Box 47143 Calgary Creekside RPO
Calgary, AB
T3P0B9

Website

Alerts

Be the first to know and let us send you an email when Canadian Association of Neuroscience Nurses posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Canadian Association of Neuroscience Nurses:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category